Caroline will have monthly blood and urine work at Vandy, and then is due back for another round of progress scans in October.
Thank you for all the support!
The Lantz Family
#carolinestrong
#ftgf
In 2017, Caroline was diagnosed with Stage IV, High-Risk Neuroblastoma: an aggressive, solid-tumor cancer that spread throughout almost all of her body, including her bone marrow. She completed a 2-year clinical trial (called DFMO) in April 2021, and relapsed in April 2022. She is currently a patient at the Monroe Carell Jr. Children's Hospital at Vanderbilt in Nashville, TN; this blog documents her journey.
Friday, July 19, 2019
Results: 3 Month Progress Scans Today
Caroline had her 3 month post-treatment progress CT and MIBG scans today at Vanderbilt, and we can happily report that she still has No Evidence of Disease! Both scans showed no signs of any tumors, so we will continue on the current path of daily doses of DFMO (clinical trial drug), to hopefully keep the cancer away!
Caroline will have monthly blood and urine work at Vandy, and then is due back for another round of progress scans in October.
Thank you for all the support!
The Lantz Family
#carolinestrong
#ftgf
Caroline will have monthly blood and urine work at Vandy, and then is due back for another round of progress scans in October.
Thank you for all the support!
The Lantz Family
#carolinestrong
#ftgf
Subscribe to:
Post Comments (Atom)
This is wonderful news!!
ReplyDeleteYayyyyy!!! Awesome news!!
ReplyDeleteFabulous news. So happy for you all!
ReplyDeleteAmen
ReplyDeleteSo glad to hear it!
ReplyDelete